Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and TaiwanCompleted
NCT04875533Phase 3Updated Nov 5, 2024
Sponsor: Pfizer
Pneumococcal Disease
Japan, South Korea, Taiwan
A First-in-human Study of Single Doses of PF-07328948 Which is Given to Healthy Adult ParticipantsCompleted
NCT05654181Phase 1Updated Nov 5, 2024
Sponsor: Pfizer
Healthy
United States
Deep rTMS and Varenicline for Smoking CessationCompleted
NCT04083144NAUpdated Nov 4, 2024
Sponsor: Centre for Addiction and Mental Health
Tobacco Use Disorder · Smoking Cessation
Canada
Talazoparib and Gemtuzumab Ozogamicin for the Treatment of CD33 Positive Relapsed or Refractory Acute Myeloid LeukemiaCompleted
NCT04207190Phase 1Updated Nov 1, 2024
Sponsor: Roswell Park Cancer Institute
Recurrent Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia
United States
Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGGTerminated
NCT03973918Phase 2Updated Oct 31, 2024
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
High Grade Glioma · BRAF V600E · BRAF V600K · Anaplastic Astrocytoma
United States
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's DiseaseCompleted
NCT03395184Phase 2Updated Oct 30, 2024
Sponsor: Pfizer
Crohn's Disease
United States, Australia, Austria, Belgium, Bosnia and Herzegovina +21 more
Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic DermatitisNo Longer Available
NCT04564755N/AUpdated Oct 29, 2024
Sponsor: Pfizer
Atopic Dermatitis
United States, Australia, Austria, Belgium, Canada +7 more
Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative ColitisCompleted
NCT05061446Phase 2Updated Oct 29, 2024
Sponsor: Pfizer
Ulcerative Colitis
Japan
Glasdegib for Chronic Graft-Versus-Host DiseaseTerminated
NCT04111497Phase 1, Phase 2Updated Oct 29, 2024
Sponsor: Fred Hutchinson Cancer Center
Chronic Graft Versus Host Disease · Fasciitis
United States
Apixaban for the Acute Treatment of Venous Thromboembolism in ChildrenCompleted
NCT02464969Phase 4Updated Oct 29, 2024
Sponsor: Bristol-Myers Squibb
Venous Thromboembolism
United States, Australia, Austria, Canada, France +8 more
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple MyelomaCompleted
NCT05932290N/AUpdated Oct 29, 2024
Sponsor: Pfizer
Multiple Myeloma
United States
A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers Co-administered the Medicine RosuvastatinCompleted
NCT05898672Phase 1Updated Oct 28, 2024
Sponsor: Pfizer
Pharmacokinetics · Healthy Volunteers
Belgium
A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant MelanomaCompleted
NCT01436656Phase 1Updated Oct 28, 2024
Sponsor: Pfizer
Melanoma and Metastatic Colorectal Cancer
United States, Australia, France, Japan, Norway +2 more
Tofacitinib (Xeljanz) Special Investigation for Rheumatoid ArthritisCompleted
NCT01932372N/AUpdated Oct 26, 2024
Sponsor: Pfizer
Rheumatoid Arthritis
Japan
A Study to Learn About the Safety and Immune Response of 20vPnC in Adults in India.Completed
NCT05875727Phase 3Updated Oct 24, 2024
Sponsor: Pfizer
Pneumococcal Disease
India
A Study of PF-07258669 In Healthy Adult ParticipantsCompleted
NCT05113940Phase 1Updated Oct 24, 2024
Sponsor: Pfizer
Healthy Participants
Belgium
A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection.Terminated
NCT04225897Phase 2Updated Oct 23, 2024
Sponsor: Pfizer
Respiratory Syncytial Virus (RSV) · Lower Resp Tract Infection
Argentina, Canada, Chile, Costa Rica, Hungary +10 more
Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese AdultsCompleted
NCT04882085Phase 4Updated Oct 21, 2024
Sponsor: Pfizer
Urinary Tract Infection · Acute Pyelonephritis · Hospital Acquired Pneumonia · Ventilator-associated Pneumonia
China
Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid ArthritisCompleted
NCT03387423N/AUpdated Oct 21, 2024
Sponsor: Pfizer
Arthritis, Rheumatoid
Germany
Study to Learn How Different Forms of The Study Medicine Called Danuglipron Are Taken up Into the Blood In Healthy AdultsCompleted
NCT06153758Phase 1Updated Oct 21, 2024
Sponsor: Pfizer
Healthy Participants · Healthy Subjects
United States
Safety, Pharmacokinetics,and Antiviral Activity of RV299 Against Respiratory Syncytical Virus (RSV)Completed
NCT06067191Phase 1Updated Oct 21, 2024
Sponsor: Pfizer
Respiratory Syncytial Virus (RSV)
United Kingdom
Use of Elranatamab in Patients With High-risk Smoldering Multiple MyelomaRecruiting
NCT06183489Phase 2Updated Oct 18, 2024
Sponsor: Stichting European Myeloma Network
Smoldering Multiple Myeloma
Finland, France, Greece, Italy, Netherlands +1 more
Study Of Sunitinib In Patients With Recurrent Paraganglioma/PheochromocytomaCompleted
NCT00843037Phase 2Updated Oct 17, 2024
Sponsor: University Health Network, Toronto
Paraganglioma · Pheochromocytoma
Canada, Netherlands
Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.Terminated
NCT03794609N/AUpdated Oct 17, 2024
Sponsor: Pfizer
Achondroplasia
United States, Australia, Belgium, Canada, China +9 more
Trial to Describe the Safety, Tolerability, and Immunogenicity of Trumenba When Administered to Immunocompromised Participants ≥10 Years of AgeCompleted
NCT04893811Phase 4Updated Oct 16, 2024
Sponsor: Pfizer
Meningococcal Vaccine
Czechia, Poland, Turkey (Türkiye)

Previous page Next page